Salta al contenuto principale
Passa alla visualizzazione normale.

SERGIO SIRAGUSA

Curriculum e ricerca

Insegnamenti

Anno accademico Codice della materia Nome della materia CFU Corso di studi
2023/2024 57014 MALATTIE DEL SANGUE (MODULO) 3 MEDICINA E CHIRURGIA
2023/2024 13253 PATOLOGIA SISTEMATICA III C.I. 6 MEDICINA E CHIRURGIA

Pubblicazioni

Data Titolo Tipologia Scheda
2023 The Role of Injectables in the Treatment and Prevention of Cancer-Associated Thrombosis Review essay (rassegna critica) Vai
2023 Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors Articolo in rivista Vai
2023 Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases Articolo in rivista Vai
2023 Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials Articolo in rivista Vai
2023 Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study Articolo in rivista Vai
2023 Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again Review essay (rassegna critica) Vai
2023 IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy Articolo in rivista Vai
2023 Immune Cells, Cytokines, and Gut Microbiota Landscape Along Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Evolution Poster pubblicato in rivista Vai
2023 Unveiling Novel Therapeutic Targets for CAR Therapy in Multiple Myeloma through Single-Cell RNA Sequencing Abstract in rivista Vai
2023 Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance Articolo in rivista Vai
2023 Ferritin Metabolism Reflects Multiple Myeloma Microenvironment and Predicts Patient Outcome Articolo in rivista Vai
2023 Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study Review essay (rassegna critica) Vai
2022 Physicians' Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform Articolo in rivista Vai
2022 Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol Articolo in rivista Vai
2022 Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine Lettera Vai
2022 The important impact of dental care on haemostatic treatment burden in patients with mild haemophilia Articolo in rivista Vai
2022 In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection Articolo in rivista Vai
2022 Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia Articolo in rivista Vai
2022 Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy Review essay (rassegna critica) Vai
2022 Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements Review essay (rassegna critica) Vai
2022 Kinesiotaping for the Treatment of Haematomas in Haemophiliacs: a Case Control Study Articolo in rivista Vai
2022 Familial essential thrombocythemia: 6 cases from a mono‐institutional series Articolo in rivista Vai
2022 High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations Review essay (rassegna critica) Vai
2022 Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma Review essay (rassegna critica) Vai
2022 Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant Articolo in rivista Vai
2022 The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity Articolo in rivista Vai
2021 Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis Articolo in rivista Vai
2021 Future directions in acquired hemophilia A Lettera Vai
2021 Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents Review essay (rassegna critica) Vai
2021 Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review Review essay (rassegna critica) Vai
2021 Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature Articolo in rivista Vai
2021 Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations Articolo in rivista Vai
2021 Bone damage after chemotherapy for lymphoma: a real-world experience Articolo in rivista Vai
2021 Immune thrombocytopenia in antiphospholipid syndrome: Is it primary or secondary? Review essay (rassegna critica) Vai
2021 Comparison between whole blood viscosity measured and calculated in subjects with monoclonal gammopathy of undetermined significance and in patients with multiple myeloma: Re-evaluation of our survey Articolo in rivista Vai
2021 Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis Articolo in rivista Vai
2021 Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy Recensione in rivista Vai
2020 Peripheral circulating cells with paroxysmal nocturnal haemoglobinuria phenotype after a first episode of cerebral sinus vein thrombosis: Results from a multicentre cross-sectional study Lettera Vai
2020 Immunoistochemical expression of PD-1 and PD-L1 in bone marrow biopsies of patients with acute myeloid leukemia Articolo in rivista Vai
2020 Plasma viscosity pattern and erythrocyte aggregation in two patients with congenital afibrinogenemia Lettera Vai
2020 Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma Articolo in rivista Vai
2020 The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors Articolo in rivista Vai
2020 Cardiovascular risk factor in MPN patients Lettera Vai
2020 CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL Articolo in rivista Vai
2020 Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up Articolo in rivista Vai
2020 Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype Review essay (rassegna critica) Vai
2020 Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric Survey Lettera Vai
2020 Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study Articolo in rivista Vai
2020 Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series Articolo in rivista Vai
2020 Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? Articolo in rivista Vai
2020 The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma Articolo in rivista Vai
2020 Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association Lettera Vai
2020 Multiple Myeloma-Derived Extracellular Vesicles Induce Osteoclastogenesis through the Activation of the XBP1/IRE1α Axis Articolo in rivista Vai
2020 Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience Articolo in rivista Vai
2020 The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep Articolo in rivista Vai
2020 Sex-related characteristics of cerebral vein thrombosis: A secondary analysis of a multicenter international cohort study Lettera Vai
2020 How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey Lettera Vai
2020 Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET Articolo in rivista Vai
2020 New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey Articolo in rivista Vai
2020 COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey Lettera Vai
2020 Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia? Articolo in rivista Vai
2019 Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry Articolo in rivista Vai
2019 Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders Lettera Vai
2019 Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogues Lettera Vai
2019 Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system Articolo in rivista Vai
2019 Personalized prophylaxis with simoctocog-alfa(human-cl rhFVIII):A real-life experience on children and moderate haemophilia A patients Abstract in atti di convegno pubblicato in rivista Vai
2019 Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis Abstract in atti di convegno pubblicato in rivista Vai
2019 Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus Articolo in rivista Vai
2019 Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:results from a short term follow-up Abstract in atti di convegno pubblicato in rivista Vai
2019 Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications Articolo in rivista Vai
2019 Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review Articolo in rivista Vai
2019 Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia Articolo in rivista Vai
2019 Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia a in Italy: Characteristics and Clinical Benefits Review essay (rassegna critica) Vai
2019 Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study Abstract in atti di convegno pubblicato in rivista Vai
2019 Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors Articolo in rivista Vai
2019 MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? Abstract in atti di convegno pubblicato in rivista Vai
2019 Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma Abstract in atti di convegno pubblicato in rivista Vai
2019 Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario Lettera Vai
2019 BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors Articolo in rivista Vai
2019 Age at diagnosis is an important prognostic factor in Philadelphia-negative Myeloproliferative Neoplasms Lettera Vai
2019 Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report Articolo in rivista Vai
2019 Detection and clinical implications of a novel BCR-ABL1 E12A2 insertion/deletion in a CML patient expressing the E13A2 isoform Articolo in rivista Vai
2019 Clinical implications of discordant early molecular responses in CML patients treated with imatinib Articolo in rivista Vai
2019 A case of severe dermatitis in a patient with Polycythemia Vera during cytoreductive therapy Articolo in rivista Vai
2019 Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry Articolo in rivista Vai
2019 Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative Lettera Vai
2019 Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study Articolo in rivista Vai
2019 Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry Articolo in rivista Vai
2018 Lymphomas and thyroid: Bridging the gap Articolo in rivista Vai
2018 Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature Review essay (rassegna critica) Vai
2018 Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs Articolo in rivista Vai
2018 Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand? Articolo in rivista Vai
2018 Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies Articolo in rivista Vai
2018 Red blood cell deformability in multiple myeloma Articolo in rivista Vai
2018 Immunosenescence and lymphomagenesis Articolo in rivista Vai
2018 Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry Lettera Vai
2017 Prolonged anticoagulant treatment in patients with cancer: Where do we stand? Recensione in rivista Vai
2017 Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy Articolo in rivista Vai
2017 Acquired haemophilia in cancer: A systematic and critical literature review Review essay (rassegna critica) Vai
2017 Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry Articolo in rivista Vai
2017 Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate Articolo in rivista Vai
2017 JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS Abstract in atti di convegno pubblicato in rivista Vai
2017 Erythrocyte deformability and hemorheological profile in multiple myeloma Articolo in rivista Vai
2017 Cardio-oncology in multiple myeloma: is it time for a specific focus? Articolo in rivista Vai
2017 Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) Articolo in rivista Vai
2017 COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. Abstract in atti di convegno pubblicato in rivista Vai
2016 Abdominal aortic thrombosis secondary to reactive thrombocytosis in a patient with iron deficiency anemia Articolo in rivista Vai
2016 Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study Articolo in rivista Vai
2015 Hematopoietic Peripheral Circulating Blood Stem Cells As an Independent Marker of Good Transfusion Management in Patients with Beta-Thalassemia Abstract in atti di convegno pubblicato in rivista Vai
2015 Management of Venous ThromboEmbolism in patients with acute leukemia at high bleeding risk: a multicenter study Articolo in rivista Vai
2015 Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. Lettera Vai
2015 The Impact of Deep Vein Thrombosis in Critically Ill Patients: A Meta-Analysis of major clinical outcomes Articolo in rivista Vai
2015 Response to Urrego et al Recensione in rivista Vai
2015 Cellule staminali ematopoietiche circolanti come marker indipendente di buon outcome clinico in pazienti con beta talassemia eedings Vai
2015 Cryopreserved platelets: from in vitro thrombin generation potential to in vivo safety Abstract in atti di convegno pubblicato in rivista Vai
2014 Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. Articolo in rivista Vai
2014 Le emergenze emorragiche in ematologia Capitolo o Saggio Vai
2013 Rivaroxaban for thromboprophylaxis in acutely ill medical patients Articolo in rivista Vai
2013 Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System eedings Vai
2013 Extended use of dabigatran, warfarin, or placebo in venous thromboembolism Abstract in rivista Vai
2013 Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia Articolo in rivista Vai
2013 Cardiovascular events and intensity of treatment in polycythemia vera. Articolo in rivista Vai
2013 Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. Articolo in rivista Vai
2013 Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses Articolo in rivista Vai
2013 Erythrocyte deformability in Polycythemia Vera eedings Vai
2013 Incidence and Management Of Venous Thrombosis In Acute Leukemia: A Multicenter Study eedings Vai
2012 ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY eedings Vai
2012 Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis Articolo in rivista Vai
2012 Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. Articolo in rivista Vai
2012 CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION eedings Vai
2012 Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry Abstract in rivista Vai
2012 Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation -a look beyond the excellent results Abstract in rivista Vai
2012 Health-related quality of life and psychological well-being in elderly patients with haemophilia Articolo in rivista Vai
2012 Long term outcomes of patients with cerebral vein thrombosis: a multicenter study. Articolo in rivista Vai
2012 CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS eedings Vai
2012 Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease Articolo in rivista Vai
2012 Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Abstract in rivista Vai
2012 Oral Communication eedings Vai
2012 PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS eedings Vai
2012 Catastrophic antiphospholipid syndrome in a patient with V Leiden variant Articolo in rivista Vai
2012 ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA eedings Vai
2012 Aspirin for preventing the recurrence of venous thromboembolism Articolo in rivista Vai
2012 Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. Articolo in rivista Vai
2012 Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study Articolo in rivista Vai
2012 Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) Articolo in rivista Vai
2012 PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE eedings Vai
2011 ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA eedings Vai
2011 Factor VII deficiency: evidence that in minor surgery one-day replacement therapy is sufficient eedings Vai
2011 Replacement Therapy for Minor Surgery and Invasive Procedures in Factor VII Deficiency: The STER Experience eedings Vai
2011 Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER Articolo in rivista Vai
2011 Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. Articolo in rivista Vai
2011 Prognostic relevance of an asymptomatic venous thromboembolism in patients with cance Articolo in rivista Vai
2011 Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Articolo in rivista Vai
2011 Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature Articolo in rivista Vai
2011 Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. Articolo in rivista Vai
2011 EGFR genomic alterations in cancer: prognostic and predictive values Articolo in rivista Vai
2010 Proposal and validation of a novel quantitative approach (QUEM) for the evaluation of menstrual blood losses. Preliminary implementation for the management of menorrhagia in congenital bleeding disorders. eedings Vai
2010 MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms Articolo in rivista Vai
2010 The Impact of Venous Thromboembolism In Critically Ill Patients: A Meta-Analysis of Major Clinical outcomes eedings Vai
2010 Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype Articolo in rivista Vai
2010 3 eedings Vai
2010 Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Articolo in rivista Vai
2010 Managing bleeding complications in patients treated with the old and the new anticoagulants. Articolo in rivista Vai
2010 Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy Articolo in rivista Vai
2010 Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma Articolo in rivista Vai
2010 Residual vein thrombosis and D-dimer for optimizing duration of anticoagulation in idiopathic deep vein thrombosis. Articolo in rivista Vai
2010 Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura -haemolytic uraemic syndrome. Articolo in rivista Vai
2010 Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab. Articolo in rivista Vai
2010 Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly. Articolo in rivista Vai
2010 Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin Articolo in rivista Vai
2010 Trisomy 11: prevalence among 22 403 unique patient cytogenetic studies and clinical correlates. Articolo in rivista Vai
2010 Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study Articolo in rivista Vai
2010 Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations. Articolo in rivista Vai
2009 Replacement Therapy for Surgery in FVII Deficiency: The Ster Experience Concerning 63 Interventions. eedings Vai
2009 ACP Journal Club. Warfarin thromboprophylaxis in cancer did not reduce risk for catheter-related thrombosis. Articolo in rivista Vai
2009 Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders Articolo in rivista Vai
2009 Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial Articolo in rivista Vai
2009 Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial Articolo in rivista Vai
2009 Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study eedings Vai
2009 Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy Articolo in rivista Vai
2009 Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with JAK2 and TET2 Mutational Status eedings Vai
2009 How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs? Articolo in rivista Vai
2009 Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins Articolo in rivista Vai
2009 Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study Articolo in rivista Vai
2009 Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Articolo in rivista Vai
2009 Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis eedings Vai
2009 Long-Term Survival Data in 652 Patients with Primary Myelofibrosis or Polycythemia Vera— Trends in Recent Years. eedings Vai
2009 Mature survival data for 176 patients younger than 60 years with primary myelofibrosis diagnosed between 1976 and 2005: evidence for survival gains in recent years Articolo in rivista Vai
2009 Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Articolo in rivista Vai
2009 Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Articolo in rivista Vai
2009 Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma. eedings Vai
2009 Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms Articolo in rivista Vai
2009 Survival in young patients with intermediate/high-risk myelofibrosis: estimates derived from databases for non transplant patients. Articolo in rivista Vai
2009 Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio. Articolo in rivista Vai
2008 Lung Immune and Coagulative Host Response in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (aeocpd). eedings Vai
2008 Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study Articolo in rivista Vai
2008 A commentary: To screen for calf DVT or not to screen? The highly variable practice among italian centers highlights this important and still unresolved clinical opinion. Results from the italian MASTER registry Articolo in rivista Vai
2008 Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis Articolo in rivista Vai
2008 Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. Articolo in rivista Vai
2008 Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. Articolo in rivista Vai
2008 Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. Articolo in rivista Vai
2008 Low molecular weight heparins as antineoplastic agents. Articolo in rivista Vai
2008 Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry Articolo in rivista Vai
2008 Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management Articolo in rivista Vai
2008 The MASTER registry on venous thromboembolism: description of the study cohort. Articolo in rivista Vai
2008 Superficial venous thrombosis: Prevalence of common genetic risk factors and their role on spreading to deep veins Articolo in rivista Vai
2008 Terapia domiciliare della Trombosi Venosa Profonda degli arti inferiori Curatela Vai
2008 Possiamo usarle in sostituzione dei cumarinici? Possiamo usarle quando pensiamo che il rischio emorragico da cumarinici sia troppo elevato? Curatela Vai
2007 PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY eedings Vai
2007 Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer. eedings Vai
2007 The risk of cardiovascular events is reduced by lowering hyperhomocysteinemia short term B vitamins therapy eedings Vai
2007 Absence of Residual Vein Thrombosis after an Episode of Idiopathic Deep Vein Thrombosis: Short-Term Anticoagulation Is Safe. The "Extended Dacus Study". eedings Vai
2007 LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY eedings Vai
2007 The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. eedings Vai
2007 THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE eedings Vai
2007 EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY eedings Vai
2007 EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES eedings Vai
2007 The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Articolo in rivista Vai
2007 Il dosaggio dell'inibitore Articolo in rivista Vai
2007 The Role of Gemtuzumab Ozogamicin in Elderly AML Patients in Complete Remission eedings Vai
2007 Deferral of assessment of pulmonary embolism Articolo in rivista Vai
2007 Low molecular weight heparins in cancer patients: to treat thromboembolic events, the tumor, of both? Articolo in rivista Vai
2007 ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS eedings Vai
2006 Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy eedings Vai
2006 Review: Long-term anticoagulation reduces recurrent venous thromboembolism Articolo in rivista Vai
2006 Limited versus extended ultrasonography for the diagnosis of clinically suspected deep vein thrombosis eedings Vai
2006 Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus eedings Vai
2006 Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report Articolo in rivista Vai
2006 Test di I livello nella diagnostica della malattia di Von Willebrand" in "Emocoagulazione ed Emostasi Monografia Vai
2006 Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients eedings Vai
2006 Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. eedings Vai
2006 Il dosaggio biologico dei fattori della coagulazione e degli inbitori del fattore VIII Monografia Vai
2006 Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia. Articolo in rivista Vai
2006 D-dimer testing: advantages and limitation in emergency medicine for managing acute venous thromboembolism Articolo in rivista Vai
2006 La gestione della terapia anticoagulante nelle procedure a rischio emorragico Curatela Vai
2005 SUPERFICIAL VENOUS THROMBOSIS: ROLE OF GENETIC RISK FACTORS ON SPREADING TO DEEP VEINS eedings Vai
2005 The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study Articolo in rivista Vai
2005 Le EBPM possono sostituire il warfarin nella prevenzione secondaria del TEV? No Curatela Vai
2005 Durata ottimale della terapia antitrombotica nei pazienti oncologici: il ruolo del trombo venoso redisuo. Lo studio "Cancer DACUS" Curatela Vai
2005 La profilassi chirurgica di pazienti con carenza congenita di FVII Curatela Vai
2005 La gestione dell'embolia polmonare non massiva: nuove evidenze sulla terapia Monografia Vai
2005 Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial eedings Vai
2005 The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease eedings Vai
2005 TROMBOSI PROFONDA SUPERFICIALE ED ESTENSIONE AL CIRCOLO PROFONDO: RUOLO DEI FATTORI DI RISCHIO GENETICI eedings Vai
2005 Un caso di emorragia gastrica post-trapianto di rene Curatela Vai
2005 Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial Articolo in rivista Vai
2005 Superficial venous thrombosis: role of genetic risk factors on spreeding to deep veins Articolo in rivista Vai
2005 Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk eedings Vai
2005 Successful treatment of acquired haemophilia with FEIBA and Retuximab eedings Vai
2005 Trombosi venosa superficiale ed estensione al circolo profondo: ruolo dei fattori di rischio genetici Abstract in rivista Vai
2005 Factor V Leiden but not prothrombin G20210A mutation is a risk factor for thrombosis in patients with lymphoproliferative disease eedings Vai
2005 Clinical experience with optional vena cava filters: results of a prospective multicenter study eedings Vai
2005 Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients Articolo in rivista Vai
2005 Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. Articolo in rivista Vai
2005 Uso del FVIIa ricombinante nell'emorragia gastrica post trapianto renale Altro Vai
2004 ISAM: international study on anticoagulation management. The Italian experience eedings Vai
2004 Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery? eedings Vai
2004 Il tromboembolismo venoso in oncoematologia Curatela Vai
2004 Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation Articolo in rivista Vai
2004 Superficial venous thrombosis and spreading to deep veins: role of genetic risk factors for venous thromboembolism Abstract in rivista Vai
2004 Markers della trombofilia nella arteriopatia cronica periferica ed eventi sichemici polidistrettuali eedings Vai
2004 Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT Articolo in rivista Vai
2004 Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis eedings Vai
2004 Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica eedings Vai
2004 Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis Articolo in rivista Vai
2004 Evaluation of patients with thrombotic stroke by methionine loading oral curve eedings Vai
2004 Sindromi emorragiche e tromboemorragiche nella patologia oncoematologica e nel trapianto di midollo Curatela Vai
2004 Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins Articolo in rivista Vai
2004 Thrombophilia in women with unexplained fetal loss eedings Vai
2002 Trombosi portale mesenterica idiopatica in paziente con doppia mutazione eterozigote del gene C677T e del gene A1298C della MTHFR Abstract in rivista Vai